PHARMAVEST ApS: Financial statements 2022
CVR: 26385180
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMAVEST ApS (CVR 26385180) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,770,660 and a net result of DKK 680,459 compared with DKK 617,952 the year before. That is an increase of 0.5% compared with the year before. Equity in the 2022 report amounted to DKK 4,857,194. The solvency ratio was 80.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,770,660
- Profit/Loss
- DKK 680,459
- Equity
- DKK 4,857,194
- Total Assets
- DKK 6,041,602
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.8 mio. | 680 t. | 4.9 mio. | 1 |
| 2021 | - | 1.8 mio. | 618 t. | 4.3 mio. | 1 |
| 2020 | - | 1.2 mio. | 281 t. | 3.8 mio. | 1 |
| 2019 | - | 1.8 mio. | 818 t. | 3.6 mio. | 1 |
| 2018 | - | 1.1 mio. | 360 t. | 2.9 mio. | 1 |
Official annual report
Keep an eye on PHARMAVEST ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMAVEST ApS has published its annual report for 2021. Gross profit came to DKK 1,761,839, and the net result was DKK 617,952.
About PHARMAVEST ApS
PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMAVEST A/S and PBH 28.037 ApS. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity in the 2025 report amounted to DKK 4,349,573.